Sandy Draper
Stock Analyst at Guggenheim
(2.93)
# 1,603
Out of 4,964 analysts
119
Total ratings
59.38%
Success rate
20.16%
Average return
Main Sectors:
Stocks Rated by Sandy Draper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Buy | $464 → $432 | $473.25 | -8.72% | 12 | Jul 24, 2024 | |
| IQV IQVIA Holdings | Downgrades: Neutral | n/a | $188.73 | - | 8 | Feb 15, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | n/a | $163.22 | - | 15 | Feb 15, 2024 | |
| EVH Evolent Health | Maintains: Hold | $36 → $34 | $9.64 | +252.70% | 9 | Nov 14, 2023 | |
| GDRX GoodRx Holdings | Maintains: Buy | $8 → $10 | $4.36 | +129.36% | 4 | Aug 10, 2023 | |
| DOCS Doximity | Downgrades: Neutral | n/a | $68.39 | - | 3 | Aug 9, 2023 | |
| TOI The Oncology Institute | Maintains: Buy | $3 → $2 | $3.48 | -42.53% | 3 | Jun 16, 2023 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $271 → $263 | $175.02 | +50.27% | 13 | Apr 28, 2023 | |
| AGL agilon health | Maintains: Buy | $21 → $30 | $1.27 | +2,262.20% | 3 | Mar 6, 2023 | |
| HQY HealthEquity | Maintains: Buy | $89 → $94 | $88.29 | +6.47% | 11 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $7.89 | - | 10 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $51 | $21.81 | +133.84% | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $143 → $129 | $167.88 | -23.16% | 2 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $55 | $29.95 | +83.64% | 2 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $226 → $168 | $46.95 | +257.83% | 2 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $12 | $44.12 | -72.80% | 1 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $33 → $38 | $26.27 | +44.65% | 7 | Feb 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $4.78 | +946.03% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $65 | $7.21 | +801.53% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $3.65 | +886.30% | 4 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $167 | $272.33 | -38.68% | 3 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.62 | - | 2 | May 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $63 | $14.05 | +348.40% | 1 | Sep 20, 2016 |
Medpace Holdings
Jul 24, 2024
Maintains: Buy
Price Target: $464 → $432
Current: $473.25
Upside: -8.72%
IQVIA Holdings
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $188.73
Upside: -
Charles River Laboratories International
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $163.22
Upside: -
Evolent Health
Nov 14, 2023
Maintains: Hold
Price Target: $36 → $34
Current: $9.64
Upside: +252.70%
GoodRx Holdings
Aug 10, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $4.36
Upside: +129.36%
Doximity
Aug 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $68.39
Upside: -
The Oncology Institute
Jun 16, 2023
Maintains: Buy
Price Target: $3 → $2
Current: $3.48
Upside: -42.53%
ICON Public Limited Company
Apr 28, 2023
Maintains: Buy
Price Target: $271 → $263
Current: $175.02
Upside: +50.27%
agilon health
Mar 6, 2023
Maintains: Buy
Price Target: $21 → $30
Current: $1.27
Upside: +2,262.20%
HealthEquity
Dec 7, 2022
Maintains: Buy
Price Target: $89 → $94
Current: $88.29
Upside: +6.47%
Oct 24, 2022
Upgrades: Neutral
Price Target: n/a
Current: $7.89
Upside: -
Aug 12, 2022
Maintains: Buy
Price Target: $36 → $51
Current: $21.81
Upside: +133.84%
May 25, 2021
Maintains: Buy
Price Target: $143 → $129
Current: $167.88
Upside: -23.16%
May 18, 2021
Maintains: Buy
Price Target: $84 → $55
Current: $29.95
Upside: +83.64%
May 12, 2021
Maintains: Buy
Price Target: $226 → $168
Current: $46.95
Upside: +257.83%
Apr 21, 2021
Initiates: Hold
Price Target: $12
Current: $44.12
Upside: -72.80%
Feb 4, 2021
Maintains: Hold
Price Target: $33 → $38
Current: $26.27
Upside: +44.65%
Jan 28, 2021
Initiates: Buy
Price Target: $50
Current: $4.78
Upside: +946.03%
Jan 28, 2021
Initiates: Buy
Price Target: $65
Current: $7.21
Upside: +801.53%
May 13, 2020
Maintains: Buy
Price Target: $30 → $36
Current: $3.65
Upside: +886.30%
Mar 26, 2020
Maintains: Buy
Price Target: $175 → $167
Current: $272.33
Upside: -38.68%
May 31, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.62
Upside: -
Sep 20, 2016
Initiates: Buy
Price Target: $63
Current: $14.05
Upside: +348.40%